Tetracycline fibers as an adjunct in the treatment of nifedipine-induced gingival enlargement

Journal of Periodontology

Volumn 76, Issue 6, 2005, Pages 1034-1039

  Sakellari, Dimitra ^a   Vouros, Ioannis D ^a   Aristodemou, Elena ^a   Konstantinidis, Antonis B ^a   Socransky, Sigmund ^b   Goodson, Max ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b FORSYTH INSTITUTE   (United States)

Author keywords

Adjunctive therapy; Chronic periodontitis; Gingival hyperplasia therapy; Nifedipine adverse effects; Periodontitis therapy; Tetracycline therapeutic use

Indexed keywords

NIFEDIPINE; TETRACYCLINE;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL SURGERY; DENTURE; DRUG TOLERABILITY; EXPERIMENTAL DESIGN; GINGIVA DISEASE; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL PARAMETERS; MEDICAL RECORD; MOUTH HYGIENE; PERIODONTITIS; TOOTH PLAQUE; TOOTH ROOT; TREATMENT PLANNING;

AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CALCIUM CHANNEL BLOCKERS; GINGIVAL OVERGROWTH; HUMANS; MALE; NIFEDIPINE; PERIODONTITIS; TETRACYCLINE;

EID: 21344440501     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.6.1034     Document Type: Article

References (21)

1. Akimoto Y, Tanaka S, Omata H, et al. Gingival hyperplasia induced by nifedipine. J Nihon Univ Sch Dent 1991; 33:174-181.
2. Bowman JM, Levy BA, Grubb RV. Gingival overgrowth induced by diltiazem. A case report. Oral Surg Oral Med Oral Pathol 1988;65:183-185.
3. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol 1984; 57:620-622.
4. Lombardi T, Fiore-Donno G, Belser U, Di Felice R. Felodipine-induced gingival hyperplasia: A clinical and histologic study. J Oral Pathol Med 1991;20:89-92.
5. Pernu HE, Oikarinen K, Hietanen J, Knuuttila M. Verapamil-induced gingival overgrowth: A clinical, histologic, and biochemic approach. J Oral Pathol Med 1989; 18:422-425.
6. Ellis JS, Seymour RA, Steele JG, et al. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999;70: 63-67.
7. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991; 2:103-137.
8. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
9. Brown RS, Sein P, Corio R, Bottomtey WK. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol 1990;70:593-596.
10. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988;15:1-16.
11. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
12. Goodson JM, Hogan PE, Dunham SL. Clinical responses following periodontal treatment by local drug delivery. J Periodontol 1985;56(Spec. Issue):81-87.
13. Goodson JM, Offenbacher S, Farr DH, Hogan PE. Periodontal disease treatment by local drug delivery. J Periodontol 1985;56:265-272.
14. Michalowicz BS, Pihlstrom BL, Drisko CL, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Maintenance response. J Periodontol 1995;66:708-715.
15. Sakellari D, Vouros I, Konstantinidis A. The use of tetracycline fibres in the treatment of generalised aggressive periodontitis: Clinical and microbiological findings. J Int Acad Periodontol 2003;5:52-60.
16. Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J Periodontol 2001;72:1241-1245.
17. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
18. Seymour RA, Smith DG, Turnbull DN. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985; 12:413-419.
19. Bullon P, Machuca G, Martinez S, et al. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. J Clin Periodontol 1996;23:649-657.
20. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000; 27:217-223.
21. Westbrook P, Bednarczyk EM, Carlson M, Sheehan H, Bissada NF. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. J Periodontol 1997;68:645-650.